Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
SELOKEN |
EINECS | N/A |
CAS No. | 74220-04-5 | Density | N/A |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | N/A | Boiling Point | N/A |
Molecular Weight | 417.456 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
N/A |
Article Data | 3 |
IUPAC Name: (2R,3R)-2,3-Dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
The MF of Seloken (CAS NO.74220-04-5) is C34H56N2O12.
The MW of Seloken (CAS NO.74220-04-5) is 684.81464.
Synonyms of Seloken (CAS NO.74220-04-5): 1-Isopropylamino-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) dextro-tartrate salt ; 2-Propanol, 1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-, (+-)-, tartrate (2:1)
Enthalpy of Vaporization: 68.47 kJ/mol
Flash Point: 194.9 °C
Boiling Point: 398.6 °C
Seloken (CAS NO.74220-04-5) is a selective adrenergic beta-1-blocking agent with no stimulatory action. It's binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | 1090mg/kg (1090mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 14, Pg. 297, 1983. | |
human | TDLo | oral | 160mg/kg (160mg/kg) | CARDIAC: PULSE RATE VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION LUNGS, THORAX, OR RESPIRATION: CYANOSIS | British Medical Journal. Vol. 1, Pg. 222, 1976. |
mouse | LD50 | intraperitoneal | 202mg/kg (202mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2439, 1982. | |
mouse | LD50 | intravenous | 84mg/kg (84mg/kg) | Drugs in Japan Vol. -, Pg. 614, 1995. | |
mouse | LD50 | oral | 1500mg/kg (1500mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 2839, 1979. |
mouse | LD50 | subcutaneous | 510mg/kg (510mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 2839, 1979. |
rabbit | LD50 | intravenous | 28700ug/kg (28.7mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 14, Pg. 297, 1983. | |
rabbit | LD50 | oral | 604mg/kg (604mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 14, Pg. 297, 1983. | |
rat | LD50 | intraperitoneal | 219mg/kg (219mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2439, 1982. | |
rat | LD50 | intravenous | 90mg/kg (90mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 2839, 1979. |
rat | LD50 | oral | 5500mg/kg (5500mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 2839, 1979. |
rat | LD50 | subcutaneous | 1150mg/kg (1150mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 2839, 1979. |
Poison by intravenous route. Moderately toxic by ingestion. Human systemic effects by ingestion: decreased blood pressure along with possible decrease in pulse rate, and cyanosis. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.